Viridian Therapeutics, Inc.\DE (VRDN) Non-Current Debt (2013 - 2026)
Viridian Therapeutics, Inc.\DE (VRDN) posted Non-Current Debt of $113.64 million for Q2 2026, up 820.0% from $12.35 million a year earlier and up 125.3% from the prior quarter.
Powered by 
Analysis
Viridian Therapeutics, Inc.\DE (VRDN) Non-Current Debt (2013 - 2026) Analysis & Trends
At the end of FY2025, Viridian Therapeutics, Inc.\DE's Non-Current Debt came in at $49.94 million, up 142.6% from FY2024.
- In prior years, Viridian Therapeutics, Inc.\DE's Non-Current Debt was $20.58 million in FY2024 (+1.9%) and $20.21 million in FY2023.
- The Q2 2026 figure stands as the highest quarterly Non-Current Debt in data going back to Q4 2016.
- On a year-over-year basis, Non-Current Debt has increased in each of the last four quarters, with growth averaging 180.1% over the last six quarters.
- According to Business Quant data, Non-Current Debt for the three prior quarters was $50.44 million (Q1 2026), $49.94 million (Q4 2025) and $20.89 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.98 Bn | 1,134.57 Bn | 19.71 Bn | 47.86 Bn |
| 2 | Johnson & Johnson | 643.66 Bn | 563.53 Bn | 17.30 Bn | 35.80 Bn |
| 3 | AbbVie | 500.95 Bn | 474.06 Bn | 12.70 Bn | 62.48 Bn |
| 4 | Merck | 358.08 Bn | 312.45 Bn | 12.21 Bn | 51.08 Bn |
| 5 | Novartis Ag | 301.84 Bn | 265.83 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 267.25 Bn | 240.94 Bn | 12.86 Bn | 23.68 Bn |
| 7 | Amgen | 241.42 Bn | 196.81 Bn | 7.24 Bn | 51.86 Bn |
| 8 | Gilead Sciences | 193.09 Bn | 167.28 Bn | 6.22 Bn | 23.83 Bn |
| 9 | Pfizer | 171.63 Bn | 118.27 Bn | 10.94 Bn | 60.50 Bn |
| 10 | Viridian Therapeutics, Inc.\DE | 2.41 Bn | -700.16 Mn | - | 113.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 113.64 Mn |
| Mar 31, 2026 | 86.53 Mn |
| Dec 31, 2025 | 84.18 Mn |
| Sep 30, 2025 | 20.89 Mn |
| Jun 30, 2025 | 12.35 Mn |
| Mar 31, 2025 | 20.69 Mn |
| Dec 31, 2024 | 20.58 Mn |
| Sep 30, 2024 | 20.52 Mn |
| Jun 30, 2024 | 17.49 Mn |
| Dec 31, 2023 | 20.21 Mn |
| Sep 30, 2020 | 4.13 Mn |
| Jun 30, 2020 | 5.38 Mn |
| Mar 31, 2020 | 10.76 Mn |
| Dec 31, 2019 | 4.33 Mn |
| Sep 30, 2019 | 14.49 Mn |
| Jun 30, 2019 | 16.33 Mn |
| Mar 31, 2019 | 17.49 Mn |
| Dec 31, 2018 | 18.30 Mn |
| Sep 30, 2018 | 19.12 Mn |
| Jun 30, 2018 | 19.93 Mn |
API Access
Viridian Therapeutics, Inc.\DE Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=VRDN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "VRDN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=VRDN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();